Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France.
History, Culture, Products & Art
Explore the main themes, entities and connections around Wockhardt. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
india manufacturing pharmaceutical khorakiwala us vaccines company habil mumbai formulations biopharmaceuticals drugs acquisitions biotechnology ltd global managing director products subsidiaries
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Wockhardt | Area served | Worldwide | 1.00 | infobox |
| Wockhardt | Founded | 1960s | 1.00 | infobox |
| Wockhardt | Founder | Habil Khorakiwala | 1.00 | infobox |
| Wockhardt | Headquarters | Wockhardt Towers, Bandra Kurla Complex, Mumbai, Maharashtra, India | 1.00 | infobox |
| Wockhardt | Industry | Pharmaceuticals Health care | 1.00 | infobox |
| Wockhardt | Key people | Habil Khorakiwala (Chairman) Murtaza Khorakiwala (Managing director) Huzaifa Khorakiwala (Executive Director) | 1.00 | infobox |
| Wockhardt | Net income | ₹−621 crore (US$−64 million) (FY23) | 1.00 | infobox |
| Wockhardt | Number of employees | 3,000 (2023) | 1.00 | infobox |
| Wockhardt | Products | Formulations Biopharmaceuticals Vaccines | 1.00 | infobox |
| Wockhardt | Revenue | ₹2,693 crore (US$280 million) (FY23) | 1.00 | infobox |
| Wockhardt | Subsidiaries | Morton Grove Pharma | 1.00 | infobox |
| Wockhardt | Traded as | NSE: WOCKPHARMA BSE: 532300 | 1.00 | infobox |
| Wockhardt | Type | Public | 1.00 | infobox |
| Wockhardt | Website | www.wockhardt.com | 1.00 | infobox |
| Wockhardt | is a | Indian pharmaceutical and biotechnology company headquartered in Mumbai | 0.90 | text |
| Wockhardt | is a | first company outside the US and Europe to manufacture recombinant human insulin.In 2011 | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.